Aspiriant LLC’s iShares Russell Mid-Cap Growth ETF IWP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.23M | Sell |
9,618
-4,139
| -30% | -$560K | 0.04% | 142 |
|
|
2025
Q4 | $1.88M | Buy |
13,757
+1,456
| +12% | +$203K | 0.05% | 117 |
|
|
2025
Q3 | $1.75M | Sell |
12,301
-12,365
| -50% | -$1.75M | 0.05% | 109 |
|
|
2025
Q2 | $3.42M | Buy |
24,666
+12,353
| +100% | +$1.56M | 0.11% | 80 |
|
|
2025
Q1 | $1.45M | Hold |
12,313
| – | – | 0.05% | 114 |
|
|
2024
Q4 | $1.56M | Hold |
12,313
| – | – | 0.06% | 110 |
|
|
2024
Q3 | $1.44M | Hold |
12,313
| – | – | 0.05% | 114 |
|
|
2024
Q2 | $1.36M | Hold |
12,313
| – | – | 0.06% | 115 |
|
|
2024
Q1 | $1.41M | Hold |
12,313
| – | – | 0.06% | 119 |
|
|
2023
Q4 | $1.29M | Hold |
12,313
| – | – | 0.06% | 124 |
|
|
2023
Q3 | $1.12M | Sell |
12,313
-88
| -0.7% | -$8.41K | 0.06% | 124 |
|
|
2023
Q2 | $1.2M | Sell |
12,401
-15
| -0.1% | -$1.37K | 0.06% | 119 |
|
|
2023
Q1 | $1.13M | Hold |
12,416
| – | – | 0.06% | 125 |
|
|
2022
Q4 | $1.04M | Sell |
12,416
-915
| -7% | -$77K | 0.05% | 128 |
|
|
2022
Q3 | $1.04M | Buy |
13,331
+915
| +7% | +$78.8K | 0.05% | 117 |
|
|
2022
Q2 | $983K | Buy |
12,416
+3,578
| +40% | +$312K | 0.05% | 123 |
|
|
2022
Q1 | $888K | Sell |
8,838
-737
| -8% | -$73.4K | 0.05% | 140 |
|
|
2021
Q4 | $1.1M | Hold |
9,575
| – | – | 0.06% | 126 |
|
|
2021
Q3 | $1.07M | Hold |
9,575
| – | – | 0.06% | 115 |
|
|
2021
Q2 | $1.08M | Sell |
9,575
-931
| -9% | -$99.4K | 0.06% | 110 |
|
|
2021
Q1 | $1.07M | Hold |
10,506
| – | – | 0.07% | 100 |
|
|
2020
Q4 | $1.08M | Sell |
10,506
-30
| -0.3% | -$2.85K | 0.07% | 94 |
|
|
2020
Q3 | $912K | Buy |
10,536
+4,846
| +85% | +$409K | 0.07% | 103 |
|
|
2020
Q2 | $450K | Buy |
5,690
+30
| +0.5% | +$2.18K | 0.04% | 133 |
|
|
2020
Q1 | $343K | Hold |
5,660
| – | – | 0.03% | 146 |
|
|
2019
Q4 | $433K | Hold |
5,660
| – | – | 0.04% | 149 |
|
|
2019
Q3 | $399K | Hold |
5,660
| – | – | 0.04% | 164 |
|
|
2019
Q2 | $404K | Sell |
5,660
-290
| -5% | -$20.2K | 0.03% | 162 |
|
|
2019
Q1 | $404K | Buy |
5,950
+290
| +5% | +$18.6K | 0.03% | 157 |
|
|
2018
Q4 | $322K | Hold |
5,660
| – | – | 0.02% | 178 |
|
|
2018
Q3 | $384K | Hold |
5,660
| – | – | 0.03% | 174 |
|
|
2018
Q2 | $359K | Sell |
5,660
-230
| -4% | -$14.5K | 0.03% | 187 |
|
|
2018
Q1 | $362K | Buy |
+5,890
| New | +$368K | 0.03% | 173 |
|
|
2017
Q4 | – | Sell |
-7,850
| Closed | -$444K | – | 130 |
|
|
2017
Q3 | $444K | Hold |
7,850
| – | – | 0.04% | 145 |
|
|
2017
Q2 | $424K | Sell |
7,850
-24
| -0.3% | -$1.28K | 0.04% | 150 |
|
|
2017
Q1 | $409K | Hold |
7,874
| – | – | 0.03% | 156 |
|
|
2016
Q4 | $383K | Hold |
7,874
| – | – | 0.03% | 149 |
|
|
2016
Q3 | $383K | Sell |
7,874
-2,600
| -25% | -$126K | 0.04% | 151 |
|
|
2016
Q2 | $507K | Buy |
10,474
+1,286
| +14% | +$59.5K | 0.05% | 138 |
|
|
2016
Q1 | $423K | Buy |
+9,188
| New | +$397K | 0.04% | 141 |
|
Other funds holding IWP
FCAS
Aspiriant LLC's IWP Position: Q1 2026 in Review
Aspiriant LLC reduced its iShares Russell Mid-Cap Growth ETF (IWP) stake by 30% in Q1 2026, selling an estimated $560K and leaving 9,618 shares worth $1.23M. The position accounts for 0.04% of the portfolio, ranked #142.
Aspiriant LLC first reported a position in IWP in Q1 2016 and has held it in 40 quarters since. The position peaked at $3.42M in Q2 2025. 1,171 funds tracked by Wall St. Rank hold IWP as of Q1 2026.
- Aspiriant LLC held 9,618 shares of iShares Russell Mid-Cap Growth ETF worth $1.23M as of Q1 2026.
- Aspiriant LLC sold 4,139 iShares Russell Mid-Cap Growth ETF shares in Q1 2026, an estimated $560K.
- iShares Russell Mid-Cap Growth ETF made up 0.04% of Aspiriant LLC's portfolio in Q1 2026, its #142 holding.
- Aspiriant LLC first reported a position in iShares Russell Mid-Cap Growth ETF in Q1 2016 and has held it in 40 quarters since.
- Aspiriant LLC's iShares Russell Mid-Cap Growth ETF position peaked at $3.42M in Q2 2025.
- 1,171 funds tracked by Wall St. Rank held iShares Russell Mid-Cap Growth ETF as of Q1 2026.
Based on Aspiriant LLC's 13F filing for Q1 2026, filed 12 May 2026.